Hyperimmune human IgG or recombinant human granulocyte-macrophage colony-stimulating factor as adjunctive therapy for group B streptococcal sepsis in newborn rats

This publication has 21 references indexed in Scilit:

• Intravenous immune globulin therapy for early-onset sepsis in premature neonates
  The Journal of Pediatrics, 1992
• Therapeutic Use of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Neonatal Rats with Type III Group B Streptococcal Sepsis
  The Journal of Infectious Diseases, 1992
• The Ability of Recombinant Murine Granulocyte-Macrophage Colony-Stimulating Factor to Protect Neonatal Rats from Septic Death Due to Staphylococcus aureus
  The Journal of Infectious Diseases, 1990
• Polyvalent Group B Streptococcal Immune Globulin for Intravenous Administration: Overview
  Clinical Infectious Diseases, 1990
• High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats
  The Journal of Pediatrics, 1989
• Correlation of clinical and pathologic findings in early onset neonatal Group B streptococcal infection with disease severity and prediction of outcome
  The Pediatric Infectious Disease Journal, 1988
• Functional Activities of Various Preparations of Human Intravenous Immunoglobulin Against Type III Group B Streptococcus
  The Journal of Infectious Diseases, 1986
• MODIFIED HUMAN IMMUNE SERUM GLOBULIN FOR INTRAVENOUS ADMINISTRATION: IN VITRO OPSONIC ACTIVITY AND IN VIVO PROTECTION AGAINST GROUP B STREPTOCOCCAL DISEASE IN SUCKLING RATS
  Acta Paediatrica, 1982
• Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection
  The Journal of Pediatrics, 1981
• Opsonic Specificity of Human Antibody to the Type III Polysaccharide of Group B Streptococcus
  The Journal of Infectious Diseases, 1979